PT  - JOURNAL ARTICLE
AU  - Xu, Stanley
AU  - Clarke, Christina
AU  - Shetterly, Susan
AU  - Narwaney, Komal
TI  - Estimating the Growth Rate and Doubling Time for Short-Term Prediction and Monitoring Trend During the COVID-19 Pandemic with a SAS Macro
AID  - 10.1101/2020.04.08.20057943
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.08.20057943
4099  - http://medrxiv.org/content/early/2020/04/20/2020.04.08.20057943.short
4100  - http://medrxiv.org/content/early/2020/04/20/2020.04.08.20057943.full
AB  - Coronavirus disease (COVID-19) has spread around the world causing tremendous stress to the US health care system. Knowing the trend of the COVID-19 pandemic is critical for the federal and local governments and health care system to prepare plans. Our aim was to develop an approach and create a SAS macro to estimate the growth rate and doubling time in days if growth rate is positive or half time in days if growth rate is negative. We fit a series of growth curves using a rolling approach. This approach was applied to the hospitalization data of Colorado State during March 13th and April 13th. The growth rate was 0.18 (95% CI=(0.11, 0.24)) and the doubling time was 5 days (95% CI= (4, 7)) for the period of March 13th-March 19th; the growth rate reached to the minimum −0.19 (95% CI= (−0.29, −0.10)) and the half time was 4 days (95% CI= (2, 6)) for the period of April 2nd – April 8th. This approach can be used for regional short-term prediction and monitoring the regional trend of the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialnoneFunding StatementThis research was supported by the Institute for Health Research, Kaiser Permanente Colorado. Xu was also supported by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data available the provided website https://coronavirus.1point3acres.com/en